Comparison of Classification of Indications for Allogeneic and Autologous Transplant for Adults in ASTCT Guidelines and Evidence Available in Published Literature

Myung S Kim; Johnny Cai; Ashray Maniar; Thomas Kartika; Alyson Haslam; Vinay Prasad

doi:10.1001/jamainternmed.2021.4826

Comparison of Classification of Indications for Allogeneic and Autologous Transplant for Adults in ASTCT Guidelines and Evidence Available in Published Literature

JAMA Intern Med. 2022 Jan 1;182(1):76-78. doi: 10.1001/jamainternmed.2021.4826.

Authors

Myung S Kim¹, Johnny Cai², Ashray Maniar³, Thomas Kartika², Alyson Haslam⁴, Vinay Prasad^{4

5}

Affiliations

¹ Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland.
² Division of Internal Medicine, Oregon Health and Science University Portland.
³ Division of Hematology Oncology, Columbia University, New York, New York.
⁴ Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco.
⁵ Department of Medicine, University of California, San Francisco, San Francisco.

Abstract

This cross-sectional study quantifies the number of randomized clinical trials in the literature for each indication for stem cell transplantation by disease type and status.

Publication types

Review

MeSH terms

Bone Marrow Transplantation / trends*
Consensus
Hematopoietic Stem Cell Transplantation / trends*
Humans
Tissue and Organ Procurement / trends*
Transplantation, Autologous / trends*
Transplantation, Homologous / trends